Synthesis of 2-styrylchromones: In vitro and in silico anticancer activity evaluation

Keyphrases

• In Silico 100%
• Anticancer Activity 100%
• Activity Evaluation 100%
• 2-Styrylchromones 100%
• Synthesized Compounds 66%
• Molecular Docking 33%
• Fourier Transform Infrared Spectroscopy (FT-IR) 33%
• Proton nuclear Magnetic Resonance 33%
• Nuclear Magnetic Resonance 33%
• 2-methylchromone 33%
• Benzaldehyde 33%
• In Silico Tests 33%
• Toxicity Test 33%
• Cancer Cells 33%
• Spectroscopic Techniques 33%
• Violet 33%
• Liquid Chromatography-high Resolution Mass Spectrometry (LC-HRMS) 33%
• Henrietta Lacks 33%
• Human Death 33%
• In Vitro Inhibition 33%
• Kinesin-5 33%
• Potential Anticancer Activity 33%
• Compound Structure 33%
• Cancer Drugs 33%
• Test Grid 33%
• Proton Testing 33%
• Aldol Condensation 33%
• Methoxy Group 33%

Medicine and Dentistry

• In Vitro 100%
• In Silico 100%
• Antineoplastic Activity 100%
• Malignant Neoplasm 66%
• Docking (Molecular) 33%
• Receptor 33%
• Cancer Cell 33%
• Spectroscopy 33%
• Proton Nuclear Magnetic Resonance 33%
• Mass Spectrum 33%
• Carbon Nuclear Magnetic Resonance 33%
• Kinesin 33%
• Toxicity Testing 33%
• Benzaldehyde Derivative 33%

Biochemistry, Genetics and Molecular Biology

• Computer Model 100%
• Antineoplastic Activity 100%
• Magnetism 66%
• Eicosanoid Receptor 33%
• Cancer Cell 33%
• Docking (Molecular) 33%
• Infrared Radiation 33%
• Spectroscopy 33%
• Fourier Transform 33%
• Grid Test 33%
• Resolution (Mass Spectrometry) 33%
• Aldol Reaction 33%
• Kinesin 33%